<p>Box and dot plots show (A) CSF sAPPα and (B) CSF sAPPß in ALS, Parkinson's disease (PD), and controls (CTRL) as well as (C) ratio CSF NfH<sup>SMI35</sup>/CSF sAPPα and (D) ratio CSF NfH<sup>SMI35</sup>/CSF sAPPß (right side). ALS fast = patients with rapid progression of disease over follow-up of 6 months, ALS slow = patients with slow progression of disease over follow-up. The box represents the 25<sup>th</sup> to 75<sup>th</sup> quartile, the whiskers represent the range, and the horizontal line in the box represents the median.</p
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease with a complex etiology th...
<p>Fig 3A shows the levels of IFN-γ in CSF of ALS patients stratified according to MFO. There are si...
<p>Four graphs (2a–2d) with levels of: sCD163 in CSF (2a); serum (2b); the sCD163 CSF/serum ratios (...
<p>Box and dot plots show CSF NfH<sup>SMI35</sup> in ALS, Parkinson's disease (PD), and controls (CT...
<p>Upper diagrams: Dot plot shows CSF sAPPα and sAPPß in patients with ALS plotted against duration ...
‡<p>Comparison across all groups, Kruskal-Wallis Analysis of Variance on Ranks.</p><p>*Comparison of...
<p>*across subgroups of ALS.</p><p>ALSFRS-R = revised Amyotrophic Lateral Sclerosis Functional Rat...
<p>(A) The levels of CSFΑβ40 were significantly lower in patients with AD and DLB compared to normal...
<p>The dot plots of CSF biomarkers in CN and AD subtypes. Bars indicates median and IQR. (A) CSF Aβ<...
<p>(A) (C) (D) The CSF CysC levels were positively correlated with CSF Αβ40 levels in AD (r = 0.312,...
<p>Fig 2 shows box plots of all biomarkers including CSF and serum concentrations as well as ratios ...
Contains fulltext : 80435.pdf (publisher's version ) (Closed access)BACKGROUND: Ce...
<p>M: male; F: Female. B: bulbar onset; L: limb onset; MFO: interval from the observation of initial...
OBJECTIVE: To test whether biomarkers for axonal degeneration correlated with clinical subtypes and ...
The neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) shar...
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease with a complex etiology th...
<p>Fig 3A shows the levels of IFN-γ in CSF of ALS patients stratified according to MFO. There are si...
<p>Four graphs (2a–2d) with levels of: sCD163 in CSF (2a); serum (2b); the sCD163 CSF/serum ratios (...
<p>Box and dot plots show CSF NfH<sup>SMI35</sup> in ALS, Parkinson's disease (PD), and controls (CT...
<p>Upper diagrams: Dot plot shows CSF sAPPα and sAPPß in patients with ALS plotted against duration ...
‡<p>Comparison across all groups, Kruskal-Wallis Analysis of Variance on Ranks.</p><p>*Comparison of...
<p>*across subgroups of ALS.</p><p>ALSFRS-R = revised Amyotrophic Lateral Sclerosis Functional Rat...
<p>(A) The levels of CSFΑβ40 were significantly lower in patients with AD and DLB compared to normal...
<p>The dot plots of CSF biomarkers in CN and AD subtypes. Bars indicates median and IQR. (A) CSF Aβ<...
<p>(A) (C) (D) The CSF CysC levels were positively correlated with CSF Αβ40 levels in AD (r = 0.312,...
<p>Fig 2 shows box plots of all biomarkers including CSF and serum concentrations as well as ratios ...
Contains fulltext : 80435.pdf (publisher's version ) (Closed access)BACKGROUND: Ce...
<p>M: male; F: Female. B: bulbar onset; L: limb onset; MFO: interval from the observation of initial...
OBJECTIVE: To test whether biomarkers for axonal degeneration correlated with clinical subtypes and ...
The neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) shar...
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a heterogeneous disease with a complex etiology th...
<p>Fig 3A shows the levels of IFN-γ in CSF of ALS patients stratified according to MFO. There are si...
<p>Four graphs (2a–2d) with levels of: sCD163 in CSF (2a); serum (2b); the sCD163 CSF/serum ratios (...